COVID-19 in a patient with a flare of systemic lupus erythematosus: A rare case-report

被引：16

作者：

Alharthy, Abdulrahman ^{[1
]}

Faqihi, Fahad ^{[1
]}

Nasim, Nasir ^{[1
]}

Noor, Alfateh ^{[1
]}

Akhtar, Saima ^{[1
]}

Balshi, Ahmed ^{[1
]}

Balhamar, Abdullah ^{[1
]}

Alqahtani, Saleh A. ^{[2
]}

Memish, Ziad A. ^{[3
]}

Karakitsos, Dimitrios ^{[1
,4
]}

机构：

[1] King Saud Med City, Crit Care Dept, POB 331905, Riyadh 11373, Saudi Arabia

[2] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21205 USA

[3] King Saud Med City, Res & Innovat Ctr, Riyadh, Saudi Arabia

[4] South Carolina Univ, Sch Med, Dept Internal Med, Columbia, SC USA

来源：

RESPIRATORY MEDICINE CASE REPORTS | 2020年 / 31卷

关键词：

COVID-19; Systemic lupus erythematosus; Acute respiratory failure; End-stage kidney disease; Steroid therapy; Hydroxychloroquine;

D O I：

10.1016/j.rmcr.2020.101252

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

This is a rare case-report of a young female with systemic lupus erythematosus and end-stage kidney disease (on maintenance hemodialysis) who was admitted to our intensive care unit due to life-threatening COVID-19. The patient was diagnosed with a flare of lupus; while being on maintenance hydroxychloroquine therapy. However, after the administration of steroids she made an uneventful recovery and was discharged home. In this report, the diagnostic dilemmas and the therapeutic challenges due to the overlapping clinical, imaging, and laboratory findings between lupus and COVID-19 pneumonitis are outlined. In conclusion, patients with lupus may be affected by COVID-19 despite the administration of hydroxychloroquine. The administration of steroids may have a beneficial effect on mitigating both the flare of SLE and the COVID-19 associated hyperinflammation.

引用

页数：4

共 4 条

[1] Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage [J].

Aguilera-Pickens, Georgina ;

Abud-Mendoza, Carlos .

REUMATOLOGIA CLINICA, 2018, 14 (05) :294-300

[2] Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome [J].

Arabi, Yaseen M. ;

Mandourah, Yasser ;

Al-Hameed, Fahad ;

Sindi, Anees A. ;

Almekhlafi, Ghaleb A. ;

Hussein, Mohamed A. ;

Jose, Jesna ;

Pinto, Ruxandra ;

Al-Omari, Awad ;

Kharaba, Ayman ;

Almotairi, Abdullah ;

Al Khatib, Kasim ;

Alraddadi, Basem ;

Shalhoub, Sarah ;

Abdulmomen, Ahmed ;

Qushmaq, Ismael ;

Mady, Ahmed ;

Solaiman, Othman ;

Al-Aithan, Abdulsalam M. ;

Al-Raddadi, Rajaa ;

Ragab, Ahmed ;

Balkhy, Hanan H. ;

Al Harthy, Abdulrahman ;

Deeb, Ahmad M. ;

Al Mutairi, Hanan ;

Al-Dawood, Abdulaziz ;

Merson, Laura ;

Hayden, Frederick G. ;

Fowler, Robert A. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (06) :757-767

[3]

Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI [10.1002/art.40930, 10.1136/annrheumdis-2018-214819]

[4]

Saudi Ministry of Health, 2020, COR DIS 19 COVID 19

← 1 →